BioNTech SE (BNTX)
86.60
-1.49
(-1.69%)
USD |
NASDAQ |
Apr 25, 12:31
BioNTech Total Assets (Quarterly): 25.43B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 25.43B |
| September 30, 2023 | 23.51B |
| June 30, 2023 | 24.15B |
| March 31, 2023 | 24.08B |
| December 31, 2022 | 24.96B |
| September 30, 2022 | 22.27B |
| June 30, 2022 | 22.10B |
| March 31, 2022 | 22.66B |
| December 31, 2021 | 17.92B |
| September 30, 2021 | 16.51B |
| Date | Value |
|---|---|
| June 30, 2021 | 10.89B |
| March 31, 2021 | 4.929B |
| December 31, 2020 | 2.852B |
| September 30, 2020 | 1.701B |
| June 30, 2020 | 1.095B |
| March 31, 2020 | 807.58M |
| December 31, 2019 | 893.50M |
| September 30, 2019 | 807.89M |
| June 30, 2019 | 821.33M |
| December 31, 2018 | 746.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
807.58M
Minimum
Mar 2020
25.43B
Maximum
Dec 2023
13.07B
Average
16.51B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 226.50B |
| BioVie Inc | 21.49M |
| Autolus Therapeutics PLC | 375.38M |
| Moderna Inc | 18.43B |
| Novavax Inc | 1.797B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.051B |
| Shareholders Equity (Quarterly) | 22.38B |
| Debt to Equity Ratio | 0.0108 |
| Current Ratio | 9.431 |
| Net Debt Paydown Yield | 0.02% |